| Roger Mills Memorial Hospital | |
| 501 South L L Males Avenue, Cheyenne, Oklahoma 73628 | |
| (580) 497-3336 | |
| Not Available |
| Name | Roger Mills Memorial Hospital |
|---|---|
| Type | Critical Access Hospital |
| Location | 501 South L L Males Avenue, Cheyenne, Oklahoma |
| Ownership | Government - Hospital District or Authority |
| Emergency Services | Yes |
| Medicare ID (CCN) | 371303 |
| NPI Number | 1497857437 |
| Organization Name | ROGER MILLS COUNTY HOSPITAL AUTHORITY |
| Doing Business As | ROGER MILLS MEMORIAL HOSPITAL |
| Address | 501 S Ll Males Ave, Cheyenne, OK 73628 |
| Hospital Type | General Acute Care Hospital - Critical Access |
| Phone Number | 580-497-3336 |
News Archive
New research from Queen Mary University of London has found youth, wealth, and being in full-time education to be risk factors associated with violent radicalisation. Contrary to popular views - religious practice, health and social inequalities, discrimination, and political engagement showed no links.
A review of Canadian data by the nation's leading lung specialists has provided the factual evidence to support what respirologists across the country have been suspecting for some time. Shockingly, more people are being admitted to Canadian hospitals each year with chronic obstructive pulmonary disease (COPD) than any other major chronic illness (including heart attacks) and that number has been increasing dramatically in recent years.
Genta Incorporated announced today the presentation of combined data on early endpoints from the Company's randomized Phase 3 trials of Genasense® (oblimersen sodium) Injection plus chemotherapy in patients with advanced melanoma. The presentation included a "pooled analysis" that assessed combined efficacy results for the endpoints of overall response and progression-free survival from both studies. The data were presented today at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL.
Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to develop and manufacture RNA Control Kits for Affymetrix. The RNA Control Kit is intended for use with in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications that Asuragen has licensed and supplied to Affymetrix.
› Verified 8 days ago
| Able to receive lab results electronically | Not Available |
| Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
New research from Queen Mary University of London has found youth, wealth, and being in full-time education to be risk factors associated with violent radicalisation. Contrary to popular views - religious practice, health and social inequalities, discrimination, and political engagement showed no links.
A review of Canadian data by the nation's leading lung specialists has provided the factual evidence to support what respirologists across the country have been suspecting for some time. Shockingly, more people are being admitted to Canadian hospitals each year with chronic obstructive pulmonary disease (COPD) than any other major chronic illness (including heart attacks) and that number has been increasing dramatically in recent years.
Genta Incorporated announced today the presentation of combined data on early endpoints from the Company's randomized Phase 3 trials of Genasense® (oblimersen sodium) Injection plus chemotherapy in patients with advanced melanoma. The presentation included a "pooled analysis" that assessed combined efficacy results for the endpoints of overall response and progression-free survival from both studies. The data were presented today at the 2010 annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL.
Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to develop and manufacture RNA Control Kits for Affymetrix. The RNA Control Kit is intended for use with in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications that Asuragen has licensed and supplied to Affymetrix.
› Verified 8 days ago
Roger Mills Memorial Hospital Critical Access Hospital Location: 501 South L L Males Avenue, Cheyenne, Oklahoma 73628 Phone: (580) 497-3336 |